Effectiveness of Atypical Versus Conventional Antipsychotics in Treating Schizophrenia

• Status: Completed
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

This study will compare the effectiveness of newer atypical antipsychotics versus older conventional antipsychotics in treating schizophrenia.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Yale University
• Collaborator: National Institute of Mental Health (NIMH)
• Treatments: Antipsychotic Agents; Olanzapine; Quetiapine Fumarate; Risperidone

Criteria

Inclusion Criteria:

• hospitalized for schizophrenia

Exclusion Criteria:

• none